Cytomegalovirus (CMV) Retinitis: A Patient Guide

Cytomegalovirus (CMV) retinitis is a serious infection of the retina that occurs when a common, typically dormant virus reactivates because the immune system has become severely weakened. In people living with advanced HIV or those undergoing intense immunosuppression after an organ or stem cell transplant, the body’s natural defenses can no longer keep the virus in check ^[1]. Once active, the virus begins to destroy the light-sensitive cells at the back of the eye, a process that can lead to permanent vision loss if it is not identified and managed promptly ^[2].

Because the infection often begins at the edges of the retina, it can be entirely “silent” in its early stages, causing no pain and no obvious change in central vision. This makes regular, dilated eye exams essential for anyone at high risk, as a specialist can often see the characteristic signs of the virus before the patient notices a single symptom ^[3]. When symptoms do appear—such as a sudden shower of “floaters,” flashes of light like a camera bulb, or a dark “curtain” falling over the field of vision—they represent a medical emergency that requires immediate evaluation to prevent irreversible damage or a retinal detachment ^[4]. If an eye specialist is unreachable after hours, go to an emergency department and identify yourself as an immunocompromised patient with CMV retinitis; do not wait for the next clinic appointment.

Managing this condition requires a dual-track strategy: using powerful antiviral medications to stop the virus from multiplying, while simultaneously working to restore the immune system’s strength. Antivirals suppress the virus, but they do not eliminate it; long-term control depends on the body’s ability to eventually take over the fight through immune recovery ^[5]. Some patients may require prolonged or indefinite suppressive therapy. This recovery is a major milestone, but it brings its own set of challenges, including inflammatory reactions that can occur as the immune system “wakes up” and begins to recognize the virus again ^[6].

Ultimately, surviving CMV retinitis is about active surveillance and a close partnership with a specialized care team. Even after the virus is dormant and the retina has healed, the remaining scars require ongoing monitoring to protect against late-stage complications. By combining modern medicine with consistent screening, it is possible to stop the progression of the disease and preserve the sight that connects you to the world ^[7].